1Issemen I,Green S.Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators[J].Nature,1990,347:645-650.
2Shi YH,Michelle H,Ronal M.Theperoxisome proliferator-activated receptorr,an integrator of transcriptional repression and nuclear receptor signling[J].PNAS,2002,99:2613-2618.
3Jiang C,Ting AT,Seed B.PPAR gamma agonists inhibit production of monocyte in inflammatory cytokines[J].Nature,1998,391:82 -86.
4Ishibashi M,Egashira K,Hiasa K,et al.Antiinflammatory and antiarteriosclerotic effects of pioglitazone[J].Hypertension,2002,40:687-693.
5Takano H,Nsakawa M.Peroxisome proliferator activated-receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes[J].Circ Res,2000,87:596-602.
6Mehrabi MR,Thalhammer T,Haslmayer P,et al.The peroxisome proliferator activated receptor gama is highly expresaed in human heart ventricles[J].Biomed Pharmacother,2002,56:407-410.
7Khandoudi N,Delerive P,Berrebi-Bertrand I,et al.Rosiglitazone,peroxisome proliferator-activated receptor-gamma,inhibits the Jun NH (2)-terminal Kinase/activating protein-1 pathway and protects the heart from ischemia/reperfusion injury[J].Diabetes,2002,51:1507-1514.
8Hsueh W,Jackson S,Aw RE,et al.Control of vascular cell proliferation and migration by PPARγ:A new approach to the macrovascular complications of diabetes[J].Dibetes-Care,2001,24 (2):392 -397.
9Wakino S.Anti-atherosclerotic effects of PPAR gamma ligands[J].Nippon Rinsho,2004,62(1):180-186.
10Youssef J,Badr M.Role of peroxisome proliferator-activated receptors in inflammation control[J].J Biomed Biotechnol,2004 (3):156-166.
2Lehman JJ,Kelly DP.Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth[J].Heart Fail Rev,2002,7(2):175-185.
3Hirayama H,Sugano M,Abe N.Troglitazone, an antidiabetic drug,improves left ventricular mass and diastolic function in normotensive diabetic patients[J].Int J Cardiol,2001,77(1):75-79.
4Rossi MA,Ramos SG,Prado CM.Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy[J].J Hypertens,2003,21(5):993-1001.
